Cosmos Holdings Announces Strategic R&D Partnership with Cloudpharm P.C. to Study the Human Gastrointestinal Microbiome and Launch Related Products Targeting on Obesity and Other Gut-Related Disorders
Accesswire
*CHICAGO, IL / ACCESSWIRE / June 30, 2022 / **Cosmos Holdings, Inc.** ("the Company") **(NASDAQ:COSM)**, *an international..